Your browser doesn't support javascript.
loading
Impact of allogeneic hematopoietic cell transplant in patients with myeloid neoplasms carrying spliceosomal mutations.
Hamilton, Betty Ky; Visconte, Valeria; Jia, Xuefei; Tabarroki, Ali; Makishima, Hideki; Hasrouni, Edy; Abounader, Donna; Kalaycio, Matt; Sekeres, Mikkael A; Sobecks, Ronald; Duong Liu, Hien; Bolwell, Brian; Maciejewski, Jaroslaw P; Copelan, Edward; Tiu, Ramon V.
Afiliação
  • Hamilton BK; Blood and Marrow Transplant Program, Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio.
  • Visconte V; Department of Translational Hematology and Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio.
  • Jia X; Department of Quantitative Health Sciences, Cleveland Clinic Lerner Research Institute, Cleveland, Ohio.
  • Tabarroki A; Department of Translational Hematology and Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio.
  • Makishima H; Department of Translational Hematology and Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio.
  • Hasrouni E; Department of Translational Hematology and Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio.
  • Abounader D; Blood and Marrow Transplant Program, Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio.
  • Kalaycio M; Blood and Marrow Transplant Program, Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio.
  • Sekeres MA; Blood and Marrow Transplant Program, Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio.
  • Sobecks R; Blood and Marrow Transplant Program, Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio.
  • Duong Liu H; Blood and Marrow Transplant Program, Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio.
  • Bolwell B; Blood and Marrow Transplant Program, Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio.
  • Maciejewski JP; Department of Translational Hematology and Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio.
  • Copelan E; Department of Hematology and Medical Oncology, Levine Cancer Institute, Carolinas HealthCare System, Charlotte, North Carolina.
  • Tiu RV; Early Phase Oncology, Eli-Lilly and Company, Indianapolis, Indiana.
Am J Hematol ; 91(4): 406-9, 2016 Jun.
Article em En | MEDLINE | ID: mdl-26799334
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide / Spliceossomos / Transplante de Células-Tronco Hematopoéticas / Mutação Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide / Spliceossomos / Transplante de Células-Tronco Hematopoéticas / Mutação Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article